3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
4
Breast Neoplasms
4
Neoplasm Metastasis
3
Lung Neoplasms
3
Triple Negative Breast Neoplasms
2
Multiple Myeloma
2
Lymphoma
2
Glioblastoma
2
Colorectal Neoplasms
2
Stroke
1
Recurrence
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Ovarian Neoplasms
1
Neurologic Manifestations
1
Myelodysplastic Syndromes
1
Motor Activity
1
Melanoma
1
Margins of Excision
1
Malignant Solid Neoplasm
1
Malignant Female Reproductive System Neoplasm
1
Localized Head and Neck Carcinoma
1
Leukemia, Myeloid, Acute
1
Leukemia
1
Inflammatory Breast Neoplasms
1
Hematologic Neoplasms
1
Fallopian Tube Neoplasms
1
Endometrial Neoplasms
1
Depression
1
Communication
1
Interventions
Cyclophosphamide
5
Etoposide
3
duvelisib
2
Vincristine
2
Prednisone
2
Melphalan
2
Doxorubicin
2
Azacitidine
2
10-propargyl-10-deazaaminopterin
2
tazemetostat
1
sodium-iodide symporter
1
ruxolitinib
1
pembrolizumab
1
fludarabine phosphate
1
fludarabine
1
etoposide phosphate
1
cemiplimab
1
belinostat
1
X-Rays
1
Whole-Body Irradiation
1
Tacrolimus
1
Specimen Handling
1
Sirolimus
1
Prednisolone
1
Photons
1
Peripheral Blood Stem Cell Transplantation
1
Nivolumab
1
Mycophenolic Acid
1
Methotrexate
1
Magnetic Resonance Spectroscopy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Immunoblastic Lymphadenopathy
×
Palliative Care
×
90 days
×
Clear all
No trials found.